Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
ARQT:NASDAQ
Arcutis Biotherapeutics Inc
$22.86
-3.75%
(-0.89) 1D
$23.40
+2.36% (+0.54)
Pre-market
Closed: Apr 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARQT...
Open
$23.75
High
$23.87
Low
$22.45
Mkt. cap
2.86B
Avg. vol.
1.23M
Volume
692.00
52-wk high
$31.77
52-wk low
$12.42
EPS
-$0.13
Beta
1.76
Shares outstanding
124.03M
No. of employees
354
News stories
From sources across the web
About Arcutis Biotherapeutics Inc
CEOFrank Watanabe
Employees354
Founded2016
HeadquartersWestlake Village, California, United States
SectorBiotechnology
Next call in 12 days
Wed, May 6, 4:30 PM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-0.06 est.)USD
Revenue / Estimate
-/ (103.66M est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
65.85M
81.50M
99.22M
129.50M
Cost of goods sold
8.83M
7.49M
8.68M
11.69M
Cost of revenue
8.83M
7.49M
8.68M
11.69M
Research and development expenses
17.54M
19.45M
19.60M
20.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
64.00M
69.17M
62.40M
78.98M
Operating expense
81.54M
88.62M
82.01M
99.43M
Total operating expenses
90.38M
96.12M
90.69M
111.12M
Operating income
-24.53M
-14.61M
8.53M
18.39M
Other non operating income
200.00K
-
-
443.00K
EBT including unusual items
-24.78M
-15.54M
7.49M
17.86M
EBT excluding unusual items
-24.78M
-15.54M
7.49M
17.86M
Income tax expense
279.00K
342.00K
80.00K
470.00K
Effective tax rate
-1.13%
-2.20%
1.07%
2.63%
Other operating expenses
-
-
-
-
Net income
-25.06M
-15.89M
7.41M
17.40M
Net profit margin
-38.06%
-19.49%
7.47%
13.43%
Earnings per share
-0.20
-0.13
0.06
0.13
Interest and investment income
2.53M
2.10M
2.04M
2.04M
Interest expense
-2.98M
-3.03M
-3.07M
-3.00M
Net interest expenses
-452.00K
-933.00K
-1.04M
-965.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.40M
-14.20M
9.09M
18.95M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more